Eucalyptus
Latest round
- Series C
Last raised
- Jan 2022
Total raised
- $72M
Investors
- 8
About Eucalyptus
Eucalyptus is an Australian-based digital healthcare company that delivers patient-centered healthcare solutions through various telehealth services across reproductive health, men's health, women's weight management, and skincare. Founded in 2019 in Sydney, Australia, Eucalyptus is a digital healthcare provider focused on delivering tailored telehealth services., a portfolio company of Institutional Venture Partners, Redpoint Ventures, Forerunner Ventures, SV Angel, Maverick Capital, Thrive Capital, Cherubic Ventures, Thrive Capital Partners, Atomic Management, Amity Supply, 7GC, Disruptive Technology Ventures, NewView Capital, and Gorilla Private Equity agreed to acquire Eucalyptus from Blackbird, Comcast Ventures, W23, OneVentures, AirTree Ventures, NewView Capital, Athletic Ventures, and Bond.15 billion. The firm was co-founded by Benny Kleist, Charlie Gearside, and Tim Doyle, who have a history of entrepreneurial ventures in healthcare. Eucalyptus specializes in digital healthcare solutions that prioritize patient-centric care across various domains, including reproductive health, men's health, women's weight management, and skincare. The company operates several digital clinics, such as Kin, Pilot, Juniper, Compound, and Software, which provide tailored telehealth services and treatment plans. Kin, launched in 2020, offers comprehensive reproductive healthcare services, including fertility care and contraceptive pill delivery, serving over 50,000 subscribers. Pilot, established in 2019, addresses men's health issues like erectile dysfunction and hair loss, while Juniper, founded in 2021, empowers women with personalized weight management programs. Compound focuses on preventative health and performance for men, and Software delivers bespoke skincare formulations. Eucalyptus operates in diverse markets including Australia, the UK, Japan, and Germany. Eucalyptus generates revenue through various channels, including direct-to-consumer subscriptions and partnerships. Clients engage with the company via subscription-based services for fertility care, contraceptive delivery, and weight management programs, ensuring ongoing access to healthcare solutions. For instance, Kin’s contraceptive delivery service operates on a subscription model, creating a steady revenue stream by charging customers for monthly deliveries. Additionally, services under Pilot and Juniper involve individualized treatment plans catering to specific health needs and goals, enhancing user engagement and retention. The company also capitalizes on retail partnerships, particularly with its skincare line, which is available in outlets such as Priceline Pharmacy, broadening its customer reach and revenue potential. The February 2026 acquisition will enable Hims & Hers to expand into Australia and Japan, deepen its presence in the UK, Germany, and Canada, and use Eucalyptus’ local teams and infrastructure to scale its international telehealth operations.
Who invested in Eucalyptus
8 investors across 4 rounds
See all investors in Eucalyptus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eucalyptus
Who invested in Eucalyptus?
Eucalyptus has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eucalyptus raised?
Eucalyptus has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Eucalyptus last raise money?
Eucalyptus's most recent round on record is a Series C, in Jan 2022.
What does Eucalyptus do?
Eucalyptus is an Australian-based digital healthcare company that delivers patient-centered healthcare solutions through various telehealth services across reproductive health, men's health, women's weight management, and skincare.
Where is Eucalyptus headquartered?
Eucalyptus is headquartered in Sydney, Australia.
Which VCs invest in companies like Eucalyptus?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back healthcare it companies at Eucalyptus's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like Eucalyptus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.